Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Amazon
AMZN
|
+$597M |
| 2 |
Meta Platforms (Facebook)
META
|
+$497M |
| 3 |
Otis Worldwide
OTIS
|
+$377M |
| 4 |
T-Mobile US
TMUS
|
+$333M |
| 5 |
AbbVie
ABBV
|
+$312M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
+$878M |
| 2 |
RTN
Raytheon Company
RTN
|
+$537M |
| 3 |
Apple
AAPL
|
+$457M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$427M |
| 5 |
Accenture
ACN
|
+$245M |
Sector Composition
| 1 | Technology | 23.73% |
| 2 | Healthcare | 14.52% |
| 3 | Financials | 12.98% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Communication Services | 9.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CALA
2376
DELISTED
Calithera Biosciences, Inc
CALA
| $4.66M | ﹤0.01% |
44,135
+3,750
| +9% | +$396K |
|
2377
Oric Pharmaceuticals
ORIC
$1.05B
| $4.66M | ﹤0.01% |
+138,126
| New | +$4.66M |
|
2378
Ribbon Communications
RBBN
$676M
| $4.65M | ﹤0.01% |
1,184,021
+123,212
| +12% | +$484K |
|
2379
Elbit Systems
ESLT
$23.6B
| $4.65M | ﹤0.01% |
33,918
-19
| -0.1% | -$2.6K |
|
2380
Utah Medical Products
UTMD
$200M
| $4.64M | ﹤0.01% |
52,366
+819
| +2% | +$72.6K |
|
2381
Hanmi Financial
HAFC
$748M
| $4.63M | ﹤0.01% |
476,630
+12,129
| +3% | +$118K |
|
2382
Vroom, Inc. Common Stock
VRM
$137M
| $4.61M | ﹤0.01% |
+1,105
| New | +$4.61M |
|
2383
Arcutis Biotherapeutics
ARQT
$2.07B
| $4.6M | ﹤0.01% |
152,262
+91,882
| +152% | +$2.78M |
|
|
WSR
2384
Whitestone REIT
WSR
$664M
| $4.57M | ﹤0.01% |
629,220
+41,931
| +7% | +$305K |
|
2385
Rigel Pharmaceuticals
RIGL
$681M
| $4.57M | ﹤0.01% |
249,938
+6,580
| +3% | +$120K |
|
2386
LendingClub
LC
$1.91B
| $4.57M | ﹤0.01% |
1,005,013
-92,033
| -8% | -$419K |
|
2387
Byline Bancorp
BY
$1.33B
| $4.57M | ﹤0.01% |
348,682
+8,524
| +3% | +$112K |
|
2388
Marcus Corp
MCS
$504M
| $4.54M | ﹤0.01% |
342,520
+13,280
| +4% | +$176K |
|
|
AKCA
2389
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $4.53M | ﹤0.01% |
330,979
+58,959
| +22% | +$808K |
|
2390
ANI Pharmaceuticals
ANIP
$2.12B
| $4.53M | ﹤0.01% |
140,132
+3,856
| +3% | +$125K |
|
2391
Cytosorbents Corp
CTSO
$58.9M
| $4.53M | ﹤0.01% |
457,757
+35,585
| +8% | +$352K |
|
2392
Haverty Furniture Companies
HVT
$371M
| $4.52M | ﹤0.01% |
282,575
-2,654
| -0.9% | -$42.5K |
|
|
AMRS
2393
DELISTED
Amyris Inc.
AMRS
| $4.52M | ﹤0.01% |
1,058,062
+311,769
| +42% | +$1.33M |
|
2394
Community Health Systems
CYH
$412M
| $4.49M | ﹤0.01% |
1,492,986
+30,925
| +2% | +$93.1K |
|
2395
Descartes Systems
DSGX
$8.96B
| $4.49M | ﹤0.01% |
85,062
+344
| +0.4% | +$18.2K |
|
|
BCOV
2396
DELISTED
Brightcove, Inc.
BCOV
| $4.48M | ﹤0.01% |
569,137
+29,168
| +5% | +$230K |
|
2397
Levi Strauss
LEVI
$8.67B
| $4.48M | ﹤0.01% |
334,463
-58,049
| -15% | -$778K |
|
|
ORBC
2398
DELISTED
ORBCOMM, Inc.
ORBC
| $4.47M | ﹤0.01% |
1,161,238
+28,444
| +3% | +$109K |
|
2399
TherapeuticsMD
TXMD
$12.8M
| $4.46M | ﹤0.01% |
71,396
+4,531
| +7% | +$283K |
|
2400
Genesco
GCO
$358M
| $4.46M | ﹤0.01% |
205,961
-1,338
| -0.6% | -$29K |
|